SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-16-000074
Filing Date
2016-08-05
Accepted
2016-08-05 16:28:58
Documents
56
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q063016.htm 10-Q 1103326
2 ex12.htm EX-12 57188
3 exhibit31_1.htm EX-31 12934
4 exhibit31_2.htm EX-31 12916
5 exhibit32_1.htm EX-32 3364
6 exhibit32_2.htm EX-32 3303
7 ex3.htm EX-3 106074
8 ex10_2.htm EX-10.2 101458
9 ex10_3.htm EX-10.3 70449
  Complete submission text file 0001367644-16-000074.txt   4678805

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT ebs-20160630.xml EX-101.INS 779211
11 XBRL TAXONOMY EXTENSION SCHEMA ebs-20160630.xsd EX-101.SCH 31139
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20160630_cal.xml EX-101.CAL 62721
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20160630_def.xml EX-101.DEF 133592
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20160630_lab.xml EX-101.LAB 471172
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20160630_pre.xml EX-101.PRE 271614
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 161811538
SIC: 2834 Pharmaceutical Preparations